Centessa Pharmaceuticals plc — Director's Dealing 2021

Jul 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2021-07-01

Reporting Person: GOYAL ARJUN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-01	Share Option (right to buy)	$22.55	A	64570	Acquired	2031-07-01	Ordinary Shares (64570)	Direct

Footnotes

F1: 1/36th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of July 1, 2021.

F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.